Global PSMA-labeled Imaging Ligands Supply, Demand and Key Producers, 2026-2032
The global PSMA-labeled Imaging Ligands market size is expected to reach $ 12023 million by 2032, rising at a market growth of 22.8% CAGR during the forecast period (2026-2032).
Prostate-specific membrane antigen (PSMA)-labeled ligands refer to small-molecule compounds that target PSMA and are conjugated with diagnostic radionuclides (primarily Gallium-68 and Fluorine-18) for PET imaging, enabling lesion detection, staging evaluation, and pre-therapeutic patient selection in prostate cancer; they do not deliver therapeutic radiation doses and are classified as radiodiagnostic agents, typically serving as a prerequisite step for PSMA-RLT. The PSMA-labeled ligand market is transitioning from early commercialization to rapid expansion, with a global effective addressable market (EAM) of approximately $2.846 billion in 2025 (including $1.679 billion in commercialized market and $1.0–1.5 billion in convertible in-house demand), corresponding to an annual scan volume of 1.5–2.0 million and a CAGR of 23.3%. Growth is primarily driven by the expansion of F-18 industrialized distribution networks in the U.S. and increasing demand for patient selection alongside broader PSMA-RLT penetration, while the Chinese market remains in an early-stage expansion phase driven by infrastructure build-out.
On the supply side, nominal “capacity” is essentially the combination of radiopharmacy network coverage and hospital nuclear medicine processing capabilities, where the Fluorine-18 system offers superior scalability through centralized cyclotron production and distribution networks, while the Gallium-68 system is constrained by generator availability and in-house operational capacity, resulting in a decentralized supply structure. In terms of pricing, F-18 finished radiopharmaceuticals (represented by Pylarify) are priced at approximately $3,000–5,000 per dose, while Ga-68 kit-based usage corresponds to $1,000–3,000 per dose; the industry overall exhibits high gross margins of 70–85% (with higher margins for kits but smaller revenue pools). Downstream applications are highly concentrated in the prostate cancer diagnostic workflow (initial staging ? recurrence detection ? RLT selection), with demand increasingly shifting toward pre-therapy selection as PSMA-targeted therapies expand. The value chain consists of upstream radionuclide supply (F-18, Ga-68 generators) and ligand synthesis, midstream radiopharmaceutical production and distribution networks (a centralized model led by Lantheus Holdings coexisting with a kit-based model led by Telix Pharmaceuticals), and downstream nuclear medicine departments and imaging centers. The global competitive landscape is characterized by an “F-18 oligopoly + Ga-68 dual-core” structure (industrial distribution dominated by Lantheus Holdings, and kit-based pathways led by Novartis and Telix Pharmaceuticals). The industry is fundamentally in a growth stage where demand has been validated but commercialization penetration remains incomplete, driven by the migration from in-house preparation to industrialized distribution and RLT-driven diagnostic demand, while the key uncertainty lies in logistical delivery radius and nuclear medicine infrastructure constraints on F-18 penetration.
This report studies the global PSMA-labeled Imaging Ligands production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PSMA-labeled Imaging Ligands and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of PSMA-labeled Imaging Ligands that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PSMA-labeled Imaging Ligands total production and demand, 2021-2032, (Units)
Global PSMA-labeled Imaging Ligands total production value, 2021-2032, (USD Million)
Global PSMA-labeled Imaging Ligands production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global PSMA-labeled Imaging Ligands consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: PSMA-labeled Imaging Ligands domestic production, consumption, key domestic manufacturers and share
Global PSMA-labeled Imaging Ligands production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global PSMA-labeled Imaging Ligands production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global PSMA-labeled Imaging Ligands production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global PSMA-labeled Imaging Ligands market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lantheus Holdings, Novartis, Curium, Blue Earth Diagnostics, Bayer, Advanced Biochemical Compounds(ABX), Yantai Dongcheng, China Isotope & Radiation, Grand Pharmaceutical, Telix Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PSMA-labeled Imaging Ligands market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global PSMA-labeled Imaging Ligands Market, By Region:
1. How big is the global PSMA-labeled Imaging Ligands market?
2. What is the demand of the global PSMA-labeled Imaging Ligands market?
3. What is the year over year growth of the global PSMA-labeled Imaging Ligands market?
4. What is the production and production value of the global PSMA-labeled Imaging Ligands market?
5. Who are the key producers in the global PSMA-labeled Imaging Ligands market?
6. What are the growth factors driving the market demand?
Prostate-specific membrane antigen (PSMA)-labeled ligands refer to small-molecule compounds that target PSMA and are conjugated with diagnostic radionuclides (primarily Gallium-68 and Fluorine-18) for PET imaging, enabling lesion detection, staging evaluation, and pre-therapeutic patient selection in prostate cancer; they do not deliver therapeutic radiation doses and are classified as radiodiagnostic agents, typically serving as a prerequisite step for PSMA-RLT. The PSMA-labeled ligand market is transitioning from early commercialization to rapid expansion, with a global effective addressable market (EAM) of approximately $2.846 billion in 2025 (including $1.679 billion in commercialized market and $1.0–1.5 billion in convertible in-house demand), corresponding to an annual scan volume of 1.5–2.0 million and a CAGR of 23.3%. Growth is primarily driven by the expansion of F-18 industrialized distribution networks in the U.S. and increasing demand for patient selection alongside broader PSMA-RLT penetration, while the Chinese market remains in an early-stage expansion phase driven by infrastructure build-out.
On the supply side, nominal “capacity” is essentially the combination of radiopharmacy network coverage and hospital nuclear medicine processing capabilities, where the Fluorine-18 system offers superior scalability through centralized cyclotron production and distribution networks, while the Gallium-68 system is constrained by generator availability and in-house operational capacity, resulting in a decentralized supply structure. In terms of pricing, F-18 finished radiopharmaceuticals (represented by Pylarify) are priced at approximately $3,000–5,000 per dose, while Ga-68 kit-based usage corresponds to $1,000–3,000 per dose; the industry overall exhibits high gross margins of 70–85% (with higher margins for kits but smaller revenue pools). Downstream applications are highly concentrated in the prostate cancer diagnostic workflow (initial staging ? recurrence detection ? RLT selection), with demand increasingly shifting toward pre-therapy selection as PSMA-targeted therapies expand. The value chain consists of upstream radionuclide supply (F-18, Ga-68 generators) and ligand synthesis, midstream radiopharmaceutical production and distribution networks (a centralized model led by Lantheus Holdings coexisting with a kit-based model led by Telix Pharmaceuticals), and downstream nuclear medicine departments and imaging centers. The global competitive landscape is characterized by an “F-18 oligopoly + Ga-68 dual-core” structure (industrial distribution dominated by Lantheus Holdings, and kit-based pathways led by Novartis and Telix Pharmaceuticals). The industry is fundamentally in a growth stage where demand has been validated but commercialization penetration remains incomplete, driven by the migration from in-house preparation to industrialized distribution and RLT-driven diagnostic demand, while the key uncertainty lies in logistical delivery radius and nuclear medicine infrastructure constraints on F-18 penetration.
This report studies the global PSMA-labeled Imaging Ligands production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PSMA-labeled Imaging Ligands and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of PSMA-labeled Imaging Ligands that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PSMA-labeled Imaging Ligands total production and demand, 2021-2032, (Units)
Global PSMA-labeled Imaging Ligands total production value, 2021-2032, (USD Million)
Global PSMA-labeled Imaging Ligands production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global PSMA-labeled Imaging Ligands consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: PSMA-labeled Imaging Ligands domestic production, consumption, key domestic manufacturers and share
Global PSMA-labeled Imaging Ligands production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global PSMA-labeled Imaging Ligands production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global PSMA-labeled Imaging Ligands production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global PSMA-labeled Imaging Ligands market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lantheus Holdings, Novartis, Curium, Blue Earth Diagnostics, Bayer, Advanced Biochemical Compounds(ABX), Yantai Dongcheng, China Isotope & Radiation, Grand Pharmaceutical, Telix Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PSMA-labeled Imaging Ligands market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global PSMA-labeled Imaging Ligands Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Gallium-68?Ga-68?
- Fluorine-18?F-18?
- Ready-to-use Drug
- Kit-based Radiolabeling
- Initial Staging
- Biochemical Recurrence
- Theranostics Selection
- Others
- Lantheus Holdings
- Novartis
- Curium
- Blue Earth Diagnostics
- Bayer
- Advanced Biochemical Compounds(ABX)
- Yantai Dongcheng
- China Isotope & Radiation
- Grand Pharmaceutical
- Telix Pharmaceuticals
1. How big is the global PSMA-labeled Imaging Ligands market?
2. What is the demand of the global PSMA-labeled Imaging Ligands market?
3. What is the year over year growth of the global PSMA-labeled Imaging Ligands market?
4. What is the production and production value of the global PSMA-labeled Imaging Ligands market?
5. Who are the key producers in the global PSMA-labeled Imaging Ligands market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 PSMA-labeled Imaging Ligands Introduction
1.2 World PSMA-labeled Imaging Ligands Supply & Forecast
1.2.1 World PSMA-labeled Imaging Ligands Production Value (2021 & 2025 & 2032)
1.2.2 World PSMA-labeled Imaging Ligands Production (2021-2032)
1.2.3 World PSMA-labeled Imaging Ligands Pricing Trends (2021-2032)
1.3 World PSMA-labeled Imaging Ligands Production by Region (Based on Production Site)
1.3.1 World PSMA-labeled Imaging Ligands Production Value by Region (2021-2032)
1.3.2 World PSMA-labeled Imaging Ligands Production by Region (2021-2032)
1.3.3 World PSMA-labeled Imaging Ligands Average Price by Region (2021-2032)
1.3.4 North America PSMA-labeled Imaging Ligands Production (2021-2032)
1.3.5 Europe PSMA-labeled Imaging Ligands Production (2021-2032)
1.3.6 China PSMA-labeled Imaging Ligands Production (2021-2032)
1.3.7 Japan PSMA-labeled Imaging Ligands Production (2021-2032)
1.3.8 India PSMA-labeled Imaging Ligands Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 PSMA-labeled Imaging Ligands Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PSMA-labeled Imaging Ligands Major Market Trends
2 DEMAND SUMMARY
2.1 World PSMA-labeled Imaging Ligands Demand (2021-2032)
2.2 World PSMA-labeled Imaging Ligands Consumption by Region
2.2.1 World PSMA-labeled Imaging Ligands Consumption by Region (2021-2026)
2.2.2 World PSMA-labeled Imaging Ligands Consumption Forecast by Region (2027-2032)
2.3 United States PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.4 China PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.5 Europe PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.6 Japan PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.7 South Korea PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.8 ASEAN PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.9 India PSMA-labeled Imaging Ligands Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PSMA-labeled Imaging Ligands Production Value by Manufacturer (2021-2026)
3.2 World PSMA-labeled Imaging Ligands Production by Manufacturer (2021-2026)
3.3 World PSMA-labeled Imaging Ligands Average Price by Manufacturer (2021-2026)
3.4 PSMA-labeled Imaging Ligands Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PSMA-labeled Imaging Ligands Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PSMA-labeled Imaging Ligands in 2025
3.5.3 Global Concentration Ratios (CR8) for PSMA-labeled Imaging Ligands in 2025
3.6 PSMA-labeled Imaging Ligands Market: Overall Company Footprint Analysis
3.6.1 PSMA-labeled Imaging Ligands Market: Region Footprint
3.6.2 PSMA-labeled Imaging Ligands Market: Company Product Type Footprint
3.6.3 PSMA-labeled Imaging Ligands Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PSMA-labeled Imaging Ligands Production Value Comparison
4.1.1 United States VS China: PSMA-labeled Imaging Ligands Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: PSMA-labeled Imaging Ligands Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: PSMA-labeled Imaging Ligands Production Comparison
4.2.1 United States VS China: PSMA-labeled Imaging Ligands Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: PSMA-labeled Imaging Ligands Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: PSMA-labeled Imaging Ligands Consumption Comparison
4.3.1 United States VS China: PSMA-labeled Imaging Ligands Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: PSMA-labeled Imaging Ligands Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based PSMA-labeled Imaging Ligands Manufacturers and Market Share, 2021-2026
4.4.1 United States Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PSMA-labeled Imaging Ligands Production Value (2021-2026)
4.4.3 United States Based Manufacturers PSMA-labeled Imaging Ligands Production (2021-2026)
4.5 China Based PSMA-labeled Imaging Ligands Manufacturers and Market Share
4.5.1 China Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PSMA-labeled Imaging Ligands Production Value (2021-2026)
4.5.3 China Based Manufacturers PSMA-labeled Imaging Ligands Production (2021-2026)
4.6 Rest of World Based PSMA-labeled Imaging Ligands Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World PSMA-labeled Imaging Ligands Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Gallium-68?Ga-68?
5.2.2 Fluorine-18?F-18?
5.3 Market Segment by Type
5.3.1 World PSMA-labeled Imaging Ligands Production by Type (2021-2032)
5.3.2 World PSMA-labeled Imaging Ligands Production Value by Type (2021-2032)
5.3.3 World PSMA-labeled Imaging Ligands Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE
6.1 World PSMA-labeled Imaging Ligands Market Size Overview by Dosage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage
6.2.1 Ready-to-use Drug
6.2.2 Kit-based Radiolabeling
6.3 Market Segment by Dosage
6.3.1 World PSMA-labeled Imaging Ligands Production by Dosage (2021-2032)
6.3.2 World PSMA-labeled Imaging Ligands Production Value by Dosage (2021-2032)
6.3.3 World PSMA-labeled Imaging Ligands Average Price by Dosage (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World PSMA-labeled Imaging Ligands Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Initial Staging
7.2.2 Biochemical Recurrence
7.2.3 Theranostics Selection
7.2.4 Others
7.3 Market Segment by Application
7.3.1 World PSMA-labeled Imaging Ligands Production by Application (2021-2032)
7.3.2 World PSMA-labeled Imaging Ligands Production Value by Application (2021-2032)
7.3.3 World PSMA-labeled Imaging Ligands Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Lantheus Holdings
8.1.1 Lantheus Holdings Details
8.1.2 Lantheus Holdings Major Business
8.1.3 Lantheus Holdings PSMA-labeled Imaging Ligands Product and Services
8.1.4 Lantheus Holdings PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Lantheus Holdings Recent Developments/Updates
8.1.6 Lantheus Holdings Competitive Strengths & Weaknesses
8.2 Novartis
8.2.1 Novartis Details
8.2.2 Novartis Major Business
8.2.3 Novartis PSMA-labeled Imaging Ligands Product and Services
8.2.4 Novartis PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Novartis Recent Developments/Updates
8.2.6 Novartis Competitive Strengths & Weaknesses
8.3 Curium
8.3.1 Curium Details
8.3.2 Curium Major Business
8.3.3 Curium PSMA-labeled Imaging Ligands Product and Services
8.3.4 Curium PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Curium Recent Developments/Updates
8.3.6 Curium Competitive Strengths & Weaknesses
8.4 Blue Earth Diagnostics
8.4.1 Blue Earth Diagnostics Details
8.4.2 Blue Earth Diagnostics Major Business
8.4.3 Blue Earth Diagnostics PSMA-labeled Imaging Ligands Product and Services
8.4.4 Blue Earth Diagnostics PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Blue Earth Diagnostics Recent Developments/Updates
8.4.6 Blue Earth Diagnostics Competitive Strengths & Weaknesses
8.5 Bayer
8.5.1 Bayer Details
8.5.2 Bayer Major Business
8.5.3 Bayer PSMA-labeled Imaging Ligands Product and Services
8.5.4 Bayer PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Bayer Recent Developments/Updates
8.5.6 Bayer Competitive Strengths & Weaknesses
8.6 Advanced Biochemical Compounds(ABX)
8.6.1 Advanced Biochemical Compounds(ABX) Details
8.6.2 Advanced Biochemical Compounds(ABX) Major Business
8.6.3 Advanced Biochemical Compounds(ABX) PSMA-labeled Imaging Ligands Product and Services
8.6.4 Advanced Biochemical Compounds(ABX) PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Advanced Biochemical Compounds(ABX) Recent Developments/Updates
8.6.6 Advanced Biochemical Compounds(ABX) Competitive Strengths & Weaknesses
8.7 Yantai Dongcheng
8.7.1 Yantai Dongcheng Details
8.7.2 Yantai Dongcheng Major Business
8.7.3 Yantai Dongcheng PSMA-labeled Imaging Ligands Product and Services
8.7.4 Yantai Dongcheng PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Yantai Dongcheng Recent Developments/Updates
8.7.6 Yantai Dongcheng Competitive Strengths & Weaknesses
8.8 China Isotope & Radiation
8.8.1 China Isotope & Radiation Details
8.8.2 China Isotope & Radiation Major Business
8.8.3 China Isotope & Radiation PSMA-labeled Imaging Ligands Product and Services
8.8.4 China Isotope & Radiation PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 China Isotope & Radiation Recent Developments/Updates
8.8.6 China Isotope & Radiation Competitive Strengths & Weaknesses
8.9 Grand Pharmaceutical
8.9.1 Grand Pharmaceutical Details
8.9.2 Grand Pharmaceutical Major Business
8.9.3 Grand Pharmaceutical PSMA-labeled Imaging Ligands Product and Services
8.9.4 Grand Pharmaceutical PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Grand Pharmaceutical Recent Developments/Updates
8.9.6 Grand Pharmaceutical Competitive Strengths & Weaknesses
8.10 Telix Pharmaceuticals
8.10.1 Telix Pharmaceuticals Details
8.10.2 Telix Pharmaceuticals Major Business
8.10.3 Telix Pharmaceuticals PSMA-labeled Imaging Ligands Product and Services
8.10.4 Telix Pharmaceuticals PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Telix Pharmaceuticals Recent Developments/Updates
8.10.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 PSMA-labeled Imaging Ligands Industry Chain
9.2 PSMA-labeled Imaging Ligands Upstream Analysis
9.2.1 PSMA-labeled Imaging Ligands Core Raw Materials
9.2.2 Main Manufacturers of PSMA-labeled Imaging Ligands Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 PSMA-labeled Imaging Ligands Production Mode
9.6 PSMA-labeled Imaging Ligands Procurement Model
9.7 PSMA-labeled Imaging Ligands Industry Sales Model and Sales Channels
9.7.1 PSMA-labeled Imaging Ligands Sales Model
9.7.2 PSMA-labeled Imaging Ligands Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 PSMA-labeled Imaging Ligands Introduction
1.2 World PSMA-labeled Imaging Ligands Supply & Forecast
1.2.1 World PSMA-labeled Imaging Ligands Production Value (2021 & 2025 & 2032)
1.2.2 World PSMA-labeled Imaging Ligands Production (2021-2032)
1.2.3 World PSMA-labeled Imaging Ligands Pricing Trends (2021-2032)
1.3 World PSMA-labeled Imaging Ligands Production by Region (Based on Production Site)
1.3.1 World PSMA-labeled Imaging Ligands Production Value by Region (2021-2032)
1.3.2 World PSMA-labeled Imaging Ligands Production by Region (2021-2032)
1.3.3 World PSMA-labeled Imaging Ligands Average Price by Region (2021-2032)
1.3.4 North America PSMA-labeled Imaging Ligands Production (2021-2032)
1.3.5 Europe PSMA-labeled Imaging Ligands Production (2021-2032)
1.3.6 China PSMA-labeled Imaging Ligands Production (2021-2032)
1.3.7 Japan PSMA-labeled Imaging Ligands Production (2021-2032)
1.3.8 India PSMA-labeled Imaging Ligands Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 PSMA-labeled Imaging Ligands Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PSMA-labeled Imaging Ligands Major Market Trends
2 DEMAND SUMMARY
2.1 World PSMA-labeled Imaging Ligands Demand (2021-2032)
2.2 World PSMA-labeled Imaging Ligands Consumption by Region
2.2.1 World PSMA-labeled Imaging Ligands Consumption by Region (2021-2026)
2.2.2 World PSMA-labeled Imaging Ligands Consumption Forecast by Region (2027-2032)
2.3 United States PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.4 China PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.5 Europe PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.6 Japan PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.7 South Korea PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.8 ASEAN PSMA-labeled Imaging Ligands Consumption (2021-2032)
2.9 India PSMA-labeled Imaging Ligands Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PSMA-labeled Imaging Ligands Production Value by Manufacturer (2021-2026)
3.2 World PSMA-labeled Imaging Ligands Production by Manufacturer (2021-2026)
3.3 World PSMA-labeled Imaging Ligands Average Price by Manufacturer (2021-2026)
3.4 PSMA-labeled Imaging Ligands Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PSMA-labeled Imaging Ligands Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PSMA-labeled Imaging Ligands in 2025
3.5.3 Global Concentration Ratios (CR8) for PSMA-labeled Imaging Ligands in 2025
3.6 PSMA-labeled Imaging Ligands Market: Overall Company Footprint Analysis
3.6.1 PSMA-labeled Imaging Ligands Market: Region Footprint
3.6.2 PSMA-labeled Imaging Ligands Market: Company Product Type Footprint
3.6.3 PSMA-labeled Imaging Ligands Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PSMA-labeled Imaging Ligands Production Value Comparison
4.1.1 United States VS China: PSMA-labeled Imaging Ligands Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: PSMA-labeled Imaging Ligands Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: PSMA-labeled Imaging Ligands Production Comparison
4.2.1 United States VS China: PSMA-labeled Imaging Ligands Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: PSMA-labeled Imaging Ligands Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: PSMA-labeled Imaging Ligands Consumption Comparison
4.3.1 United States VS China: PSMA-labeled Imaging Ligands Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: PSMA-labeled Imaging Ligands Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based PSMA-labeled Imaging Ligands Manufacturers and Market Share, 2021-2026
4.4.1 United States Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PSMA-labeled Imaging Ligands Production Value (2021-2026)
4.4.3 United States Based Manufacturers PSMA-labeled Imaging Ligands Production (2021-2026)
4.5 China Based PSMA-labeled Imaging Ligands Manufacturers and Market Share
4.5.1 China Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PSMA-labeled Imaging Ligands Production Value (2021-2026)
4.5.3 China Based Manufacturers PSMA-labeled Imaging Ligands Production (2021-2026)
4.6 Rest of World Based PSMA-labeled Imaging Ligands Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World PSMA-labeled Imaging Ligands Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Gallium-68?Ga-68?
5.2.2 Fluorine-18?F-18?
5.3 Market Segment by Type
5.3.1 World PSMA-labeled Imaging Ligands Production by Type (2021-2032)
5.3.2 World PSMA-labeled Imaging Ligands Production Value by Type (2021-2032)
5.3.3 World PSMA-labeled Imaging Ligands Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE
6.1 World PSMA-labeled Imaging Ligands Market Size Overview by Dosage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage
6.2.1 Ready-to-use Drug
6.2.2 Kit-based Radiolabeling
6.3 Market Segment by Dosage
6.3.1 World PSMA-labeled Imaging Ligands Production by Dosage (2021-2032)
6.3.2 World PSMA-labeled Imaging Ligands Production Value by Dosage (2021-2032)
6.3.3 World PSMA-labeled Imaging Ligands Average Price by Dosage (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World PSMA-labeled Imaging Ligands Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Initial Staging
7.2.2 Biochemical Recurrence
7.2.3 Theranostics Selection
7.2.4 Others
7.3 Market Segment by Application
7.3.1 World PSMA-labeled Imaging Ligands Production by Application (2021-2032)
7.3.2 World PSMA-labeled Imaging Ligands Production Value by Application (2021-2032)
7.3.3 World PSMA-labeled Imaging Ligands Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Lantheus Holdings
8.1.1 Lantheus Holdings Details
8.1.2 Lantheus Holdings Major Business
8.1.3 Lantheus Holdings PSMA-labeled Imaging Ligands Product and Services
8.1.4 Lantheus Holdings PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Lantheus Holdings Recent Developments/Updates
8.1.6 Lantheus Holdings Competitive Strengths & Weaknesses
8.2 Novartis
8.2.1 Novartis Details
8.2.2 Novartis Major Business
8.2.3 Novartis PSMA-labeled Imaging Ligands Product and Services
8.2.4 Novartis PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Novartis Recent Developments/Updates
8.2.6 Novartis Competitive Strengths & Weaknesses
8.3 Curium
8.3.1 Curium Details
8.3.2 Curium Major Business
8.3.3 Curium PSMA-labeled Imaging Ligands Product and Services
8.3.4 Curium PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Curium Recent Developments/Updates
8.3.6 Curium Competitive Strengths & Weaknesses
8.4 Blue Earth Diagnostics
8.4.1 Blue Earth Diagnostics Details
8.4.2 Blue Earth Diagnostics Major Business
8.4.3 Blue Earth Diagnostics PSMA-labeled Imaging Ligands Product and Services
8.4.4 Blue Earth Diagnostics PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Blue Earth Diagnostics Recent Developments/Updates
8.4.6 Blue Earth Diagnostics Competitive Strengths & Weaknesses
8.5 Bayer
8.5.1 Bayer Details
8.5.2 Bayer Major Business
8.5.3 Bayer PSMA-labeled Imaging Ligands Product and Services
8.5.4 Bayer PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Bayer Recent Developments/Updates
8.5.6 Bayer Competitive Strengths & Weaknesses
8.6 Advanced Biochemical Compounds(ABX)
8.6.1 Advanced Biochemical Compounds(ABX) Details
8.6.2 Advanced Biochemical Compounds(ABX) Major Business
8.6.3 Advanced Biochemical Compounds(ABX) PSMA-labeled Imaging Ligands Product and Services
8.6.4 Advanced Biochemical Compounds(ABX) PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Advanced Biochemical Compounds(ABX) Recent Developments/Updates
8.6.6 Advanced Biochemical Compounds(ABX) Competitive Strengths & Weaknesses
8.7 Yantai Dongcheng
8.7.1 Yantai Dongcheng Details
8.7.2 Yantai Dongcheng Major Business
8.7.3 Yantai Dongcheng PSMA-labeled Imaging Ligands Product and Services
8.7.4 Yantai Dongcheng PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Yantai Dongcheng Recent Developments/Updates
8.7.6 Yantai Dongcheng Competitive Strengths & Weaknesses
8.8 China Isotope & Radiation
8.8.1 China Isotope & Radiation Details
8.8.2 China Isotope & Radiation Major Business
8.8.3 China Isotope & Radiation PSMA-labeled Imaging Ligands Product and Services
8.8.4 China Isotope & Radiation PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 China Isotope & Radiation Recent Developments/Updates
8.8.6 China Isotope & Radiation Competitive Strengths & Weaknesses
8.9 Grand Pharmaceutical
8.9.1 Grand Pharmaceutical Details
8.9.2 Grand Pharmaceutical Major Business
8.9.3 Grand Pharmaceutical PSMA-labeled Imaging Ligands Product and Services
8.9.4 Grand Pharmaceutical PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Grand Pharmaceutical Recent Developments/Updates
8.9.6 Grand Pharmaceutical Competitive Strengths & Weaknesses
8.10 Telix Pharmaceuticals
8.10.1 Telix Pharmaceuticals Details
8.10.2 Telix Pharmaceuticals Major Business
8.10.3 Telix Pharmaceuticals PSMA-labeled Imaging Ligands Product and Services
8.10.4 Telix Pharmaceuticals PSMA-labeled Imaging Ligands Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Telix Pharmaceuticals Recent Developments/Updates
8.10.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 PSMA-labeled Imaging Ligands Industry Chain
9.2 PSMA-labeled Imaging Ligands Upstream Analysis
9.2.1 PSMA-labeled Imaging Ligands Core Raw Materials
9.2.2 Main Manufacturers of PSMA-labeled Imaging Ligands Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 PSMA-labeled Imaging Ligands Production Mode
9.6 PSMA-labeled Imaging Ligands Procurement Model
9.7 PSMA-labeled Imaging Ligands Industry Sales Model and Sales Channels
9.7.1 PSMA-labeled Imaging Ligands Sales Model
9.7.2 PSMA-labeled Imaging Ligands Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World PSMA-labeled Imaging Ligands Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World PSMA-labeled Imaging Ligands Production Value by Region (2021-2026) & (USD Million)
Table 3. World PSMA-labeled Imaging Ligands Production Value by Region (2027-2032) & (USD Million)
Table 4. World PSMA-labeled Imaging Ligands Production Value Market Share by Region (2021-2026)
Table 5. World PSMA-labeled Imaging Ligands Production Value Market Share by Region (2027-2032)
Table 6. World PSMA-labeled Imaging Ligands Production by Region (2021-2026) & (Units)
Table 7. World PSMA-labeled Imaging Ligands Production by Region (2027-2032) & (Units)
Table 8. World PSMA-labeled Imaging Ligands Production Market Share by Region (2021-2026)
Table 9. World PSMA-labeled Imaging Ligands Production Market Share by Region (2027-2032)
Table 10. World PSMA-labeled Imaging Ligands Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World PSMA-labeled Imaging Ligands Average Price by Region (2027-2032) & (US$/Unit)
Table 12. PSMA-labeled Imaging Ligands Major Market Trends
Table 13. World PSMA-labeled Imaging Ligands Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World PSMA-labeled Imaging Ligands Consumption by Region (2021-2026) & (Units)
Table 15. World PSMA-labeled Imaging Ligands Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World PSMA-labeled Imaging Ligands Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key PSMA-labeled Imaging Ligands Producers in 2025
Table 18. World PSMA-labeled Imaging Ligands Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key PSMA-labeled Imaging Ligands Producers in 2025
Table 20. World PSMA-labeled Imaging Ligands Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global PSMA-labeled Imaging Ligands Company Evaluation Quadrant
Table 22. World PSMA-labeled Imaging Ligands Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and PSMA-labeled Imaging Ligands Production Site of Key Manufacturer
Table 24. PSMA-labeled Imaging Ligands Market: Company Product Type Footprint
Table 25. PSMA-labeled Imaging Ligands Market: Company Product Application Footprint
Table 26. PSMA-labeled Imaging Ligands Competitive Factors
Table 27. PSMA-labeled Imaging Ligands New Entrant and Capacity Expansion Plans
Table 28. PSMA-labeled Imaging Ligands Mergers & Acquisitions Activity
Table 29. United States VS China PSMA-labeled Imaging Ligands Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China PSMA-labeled Imaging Ligands Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China PSMA-labeled Imaging Ligands Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PSMA-labeled Imaging Ligands Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers PSMA-labeled Imaging Ligands Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers PSMA-labeled Imaging Ligands Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share (2021-2026)
Table 37. China Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PSMA-labeled Imaging Ligands Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers PSMA-labeled Imaging Ligands Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers PSMA-labeled Imaging Ligands Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share (2021-2026)
Table 42. Rest of World Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share (2021-2026)
Table 47. World PSMA-labeled Imaging Ligands Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World PSMA-labeled Imaging Ligands Production by Type (2021-2026) & (Units)
Table 49. World PSMA-labeled Imaging Ligands Production by Type (2027-2032) & (Units)
Table 50. World PSMA-labeled Imaging Ligands Production Value by Type (2021-2026) & (USD Million)
Table 51. World PSMA-labeled Imaging Ligands Production Value by Type (2027-2032) & (USD Million)
Table 52. World PSMA-labeled Imaging Ligands Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World PSMA-labeled Imaging Ligands Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World PSMA-labeled Imaging Ligands Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Table 55. World PSMA-labeled Imaging Ligands Production by Dosage (2021-2026) & (Units)
Table 56. World PSMA-labeled Imaging Ligands Production by Dosage (2027-2032) & (Units)
Table 57. World PSMA-labeled Imaging Ligands Production Value by Dosage (2021-2026) & (USD Million)
Table 58. World PSMA-labeled Imaging Ligands Production Value by Dosage (2027-2032) & (USD Million)
Table 59. World PSMA-labeled Imaging Ligands Average Price by Dosage (2021-2026) & (US$/Unit)
Table 60. World PSMA-labeled Imaging Ligands Average Price by Dosage (2027-2032) & (US$/Unit)
Table 61. World PSMA-labeled Imaging Ligands Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World PSMA-labeled Imaging Ligands Production by Application (2021-2026) & (Units)
Table 63. World PSMA-labeled Imaging Ligands Production by Application (2027-2032) & (Units)
Table 64. World PSMA-labeled Imaging Ligands Production Value by Application (2021-2026) & (USD Million)
Table 65. World PSMA-labeled Imaging Ligands Production Value by Application (2027-2032) & (USD Million)
Table 66. World PSMA-labeled Imaging Ligands Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World PSMA-labeled Imaging Ligands Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Lantheus Holdings Basic Information, Manufacturing Base and Competitors
Table 69. Lantheus Holdings Major Business
Table 70. Lantheus Holdings PSMA-labeled Imaging Ligands Product and Services
Table 71. Lantheus Holdings PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Lantheus Holdings Recent Developments/Updates
Table 73. Lantheus Holdings Competitive Strengths & Weaknesses
Table 74. Novartis Basic Information, Manufacturing Base and Competitors
Table 75. Novartis Major Business
Table 76. Novartis PSMA-labeled Imaging Ligands Product and Services
Table 77. Novartis PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Novartis Recent Developments/Updates
Table 79. Novartis Competitive Strengths & Weaknesses
Table 80. Curium Basic Information, Manufacturing Base and Competitors
Table 81. Curium Major Business
Table 82. Curium PSMA-labeled Imaging Ligands Product and Services
Table 83. Curium PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Curium Recent Developments/Updates
Table 85. Curium Competitive Strengths & Weaknesses
Table 86. Blue Earth Diagnostics Basic Information, Manufacturing Base and Competitors
Table 87. Blue Earth Diagnostics Major Business
Table 88. Blue Earth Diagnostics PSMA-labeled Imaging Ligands Product and Services
Table 89. Blue Earth Diagnostics PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Blue Earth Diagnostics Recent Developments/Updates
Table 91. Blue Earth Diagnostics Competitive Strengths & Weaknesses
Table 92. Bayer Basic Information, Manufacturing Base and Competitors
Table 93. Bayer Major Business
Table 94. Bayer PSMA-labeled Imaging Ligands Product and Services
Table 95. Bayer PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Bayer Recent Developments/Updates
Table 97. Bayer Competitive Strengths & Weaknesses
Table 98. Advanced Biochemical Compounds(ABX) Basic Information, Manufacturing Base and Competitors
Table 99. Advanced Biochemical Compounds(ABX) Major Business
Table 100. Advanced Biochemical Compounds(ABX) PSMA-labeled Imaging Ligands Product and Services
Table 101. Advanced Biochemical Compounds(ABX) PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Advanced Biochemical Compounds(ABX) Recent Developments/Updates
Table 103. Advanced Biochemical Compounds(ABX) Competitive Strengths & Weaknesses
Table 104. Yantai Dongcheng Basic Information, Manufacturing Base and Competitors
Table 105. Yantai Dongcheng Major Business
Table 106. Yantai Dongcheng PSMA-labeled Imaging Ligands Product and Services
Table 107. Yantai Dongcheng PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Yantai Dongcheng Recent Developments/Updates
Table 109. Yantai Dongcheng Competitive Strengths & Weaknesses
Table 110. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 111. China Isotope & Radiation Major Business
Table 112. China Isotope & Radiation PSMA-labeled Imaging Ligands Product and Services
Table 113. China Isotope & Radiation PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. China Isotope & Radiation Recent Developments/Updates
Table 115. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 116. Grand Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 117. Grand Pharmaceutical Major Business
Table 118. Grand Pharmaceutical PSMA-labeled Imaging Ligands Product and Services
Table 119. Grand Pharmaceutical PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Grand Pharmaceutical Recent Developments/Updates
Table 121. Grand Pharmaceutical Competitive Strengths & Weaknesses
Table 122. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 123. Telix Pharmaceuticals Major Business
Table 124. Telix Pharmaceuticals PSMA-labeled Imaging Ligands Product and Services
Table 125. Telix Pharmaceuticals PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Telix Pharmaceuticals Recent Developments/Updates
Table 127. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 128. Global Key Players of PSMA-labeled Imaging Ligands Upstream (Raw Materials)
Table 129. Global PSMA-labeled Imaging Ligands Typical Customers
Table 130. PSMA-labeled Imaging Ligands Typical Distributors
Table 1. World PSMA-labeled Imaging Ligands Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World PSMA-labeled Imaging Ligands Production Value by Region (2021-2026) & (USD Million)
Table 3. World PSMA-labeled Imaging Ligands Production Value by Region (2027-2032) & (USD Million)
Table 4. World PSMA-labeled Imaging Ligands Production Value Market Share by Region (2021-2026)
Table 5. World PSMA-labeled Imaging Ligands Production Value Market Share by Region (2027-2032)
Table 6. World PSMA-labeled Imaging Ligands Production by Region (2021-2026) & (Units)
Table 7. World PSMA-labeled Imaging Ligands Production by Region (2027-2032) & (Units)
Table 8. World PSMA-labeled Imaging Ligands Production Market Share by Region (2021-2026)
Table 9. World PSMA-labeled Imaging Ligands Production Market Share by Region (2027-2032)
Table 10. World PSMA-labeled Imaging Ligands Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World PSMA-labeled Imaging Ligands Average Price by Region (2027-2032) & (US$/Unit)
Table 12. PSMA-labeled Imaging Ligands Major Market Trends
Table 13. World PSMA-labeled Imaging Ligands Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World PSMA-labeled Imaging Ligands Consumption by Region (2021-2026) & (Units)
Table 15. World PSMA-labeled Imaging Ligands Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World PSMA-labeled Imaging Ligands Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key PSMA-labeled Imaging Ligands Producers in 2025
Table 18. World PSMA-labeled Imaging Ligands Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key PSMA-labeled Imaging Ligands Producers in 2025
Table 20. World PSMA-labeled Imaging Ligands Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global PSMA-labeled Imaging Ligands Company Evaluation Quadrant
Table 22. World PSMA-labeled Imaging Ligands Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and PSMA-labeled Imaging Ligands Production Site of Key Manufacturer
Table 24. PSMA-labeled Imaging Ligands Market: Company Product Type Footprint
Table 25. PSMA-labeled Imaging Ligands Market: Company Product Application Footprint
Table 26. PSMA-labeled Imaging Ligands Competitive Factors
Table 27. PSMA-labeled Imaging Ligands New Entrant and Capacity Expansion Plans
Table 28. PSMA-labeled Imaging Ligands Mergers & Acquisitions Activity
Table 29. United States VS China PSMA-labeled Imaging Ligands Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China PSMA-labeled Imaging Ligands Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China PSMA-labeled Imaging Ligands Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PSMA-labeled Imaging Ligands Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers PSMA-labeled Imaging Ligands Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers PSMA-labeled Imaging Ligands Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share (2021-2026)
Table 37. China Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PSMA-labeled Imaging Ligands Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers PSMA-labeled Imaging Ligands Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers PSMA-labeled Imaging Ligands Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share (2021-2026)
Table 42. Rest of World Based PSMA-labeled Imaging Ligands Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share (2021-2026)
Table 47. World PSMA-labeled Imaging Ligands Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World PSMA-labeled Imaging Ligands Production by Type (2021-2026) & (Units)
Table 49. World PSMA-labeled Imaging Ligands Production by Type (2027-2032) & (Units)
Table 50. World PSMA-labeled Imaging Ligands Production Value by Type (2021-2026) & (USD Million)
Table 51. World PSMA-labeled Imaging Ligands Production Value by Type (2027-2032) & (USD Million)
Table 52. World PSMA-labeled Imaging Ligands Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World PSMA-labeled Imaging Ligands Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World PSMA-labeled Imaging Ligands Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Table 55. World PSMA-labeled Imaging Ligands Production by Dosage (2021-2026) & (Units)
Table 56. World PSMA-labeled Imaging Ligands Production by Dosage (2027-2032) & (Units)
Table 57. World PSMA-labeled Imaging Ligands Production Value by Dosage (2021-2026) & (USD Million)
Table 58. World PSMA-labeled Imaging Ligands Production Value by Dosage (2027-2032) & (USD Million)
Table 59. World PSMA-labeled Imaging Ligands Average Price by Dosage (2021-2026) & (US$/Unit)
Table 60. World PSMA-labeled Imaging Ligands Average Price by Dosage (2027-2032) & (US$/Unit)
Table 61. World PSMA-labeled Imaging Ligands Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World PSMA-labeled Imaging Ligands Production by Application (2021-2026) & (Units)
Table 63. World PSMA-labeled Imaging Ligands Production by Application (2027-2032) & (Units)
Table 64. World PSMA-labeled Imaging Ligands Production Value by Application (2021-2026) & (USD Million)
Table 65. World PSMA-labeled Imaging Ligands Production Value by Application (2027-2032) & (USD Million)
Table 66. World PSMA-labeled Imaging Ligands Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World PSMA-labeled Imaging Ligands Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Lantheus Holdings Basic Information, Manufacturing Base and Competitors
Table 69. Lantheus Holdings Major Business
Table 70. Lantheus Holdings PSMA-labeled Imaging Ligands Product and Services
Table 71. Lantheus Holdings PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Lantheus Holdings Recent Developments/Updates
Table 73. Lantheus Holdings Competitive Strengths & Weaknesses
Table 74. Novartis Basic Information, Manufacturing Base and Competitors
Table 75. Novartis Major Business
Table 76. Novartis PSMA-labeled Imaging Ligands Product and Services
Table 77. Novartis PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Novartis Recent Developments/Updates
Table 79. Novartis Competitive Strengths & Weaknesses
Table 80. Curium Basic Information, Manufacturing Base and Competitors
Table 81. Curium Major Business
Table 82. Curium PSMA-labeled Imaging Ligands Product and Services
Table 83. Curium PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Curium Recent Developments/Updates
Table 85. Curium Competitive Strengths & Weaknesses
Table 86. Blue Earth Diagnostics Basic Information, Manufacturing Base and Competitors
Table 87. Blue Earth Diagnostics Major Business
Table 88. Blue Earth Diagnostics PSMA-labeled Imaging Ligands Product and Services
Table 89. Blue Earth Diagnostics PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Blue Earth Diagnostics Recent Developments/Updates
Table 91. Blue Earth Diagnostics Competitive Strengths & Weaknesses
Table 92. Bayer Basic Information, Manufacturing Base and Competitors
Table 93. Bayer Major Business
Table 94. Bayer PSMA-labeled Imaging Ligands Product and Services
Table 95. Bayer PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Bayer Recent Developments/Updates
Table 97. Bayer Competitive Strengths & Weaknesses
Table 98. Advanced Biochemical Compounds(ABX) Basic Information, Manufacturing Base and Competitors
Table 99. Advanced Biochemical Compounds(ABX) Major Business
Table 100. Advanced Biochemical Compounds(ABX) PSMA-labeled Imaging Ligands Product and Services
Table 101. Advanced Biochemical Compounds(ABX) PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Advanced Biochemical Compounds(ABX) Recent Developments/Updates
Table 103. Advanced Biochemical Compounds(ABX) Competitive Strengths & Weaknesses
Table 104. Yantai Dongcheng Basic Information, Manufacturing Base and Competitors
Table 105. Yantai Dongcheng Major Business
Table 106. Yantai Dongcheng PSMA-labeled Imaging Ligands Product and Services
Table 107. Yantai Dongcheng PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Yantai Dongcheng Recent Developments/Updates
Table 109. Yantai Dongcheng Competitive Strengths & Weaknesses
Table 110. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 111. China Isotope & Radiation Major Business
Table 112. China Isotope & Radiation PSMA-labeled Imaging Ligands Product and Services
Table 113. China Isotope & Radiation PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. China Isotope & Radiation Recent Developments/Updates
Table 115. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 116. Grand Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 117. Grand Pharmaceutical Major Business
Table 118. Grand Pharmaceutical PSMA-labeled Imaging Ligands Product and Services
Table 119. Grand Pharmaceutical PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Grand Pharmaceutical Recent Developments/Updates
Table 121. Grand Pharmaceutical Competitive Strengths & Weaknesses
Table 122. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 123. Telix Pharmaceuticals Major Business
Table 124. Telix Pharmaceuticals PSMA-labeled Imaging Ligands Product and Services
Table 125. Telix Pharmaceuticals PSMA-labeled Imaging Ligands Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Telix Pharmaceuticals Recent Developments/Updates
Table 127. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 128. Global Key Players of PSMA-labeled Imaging Ligands Upstream (Raw Materials)
Table 129. Global PSMA-labeled Imaging Ligands Typical Customers
Table 130. PSMA-labeled Imaging Ligands Typical Distributors
LIST OF FIGURES
Figure 1. PSMA-labeled Imaging Ligands Picture
Figure 2. World PSMA-labeled Imaging Ligands Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World PSMA-labeled Imaging Ligands Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 5. World PSMA-labeled Imaging Ligands Average Price (2021-2032) & (US$/Unit)
Figure 6. World PSMA-labeled Imaging Ligands Production Value Market Share by Region (2021-2032)
Figure 7. World PSMA-labeled Imaging Ligands Production Market Share by Region (2021-2032)
Figure 8. North America PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 9. Europe PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 10. China PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 11. Japan PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 12. India PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 13. PSMA-labeled Imaging Ligands Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 16. World PSMA-labeled Imaging Ligands Consumption Market Share by Region (2021-2032)
Figure 17. United States PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 18. China PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 19. Europe PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 20. Japan PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 21. South Korea PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 22. ASEAN PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 23. India PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of PSMA-labeled Imaging Ligands by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for PSMA-labeled Imaging Ligands Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for PSMA-labeled Imaging Ligands Markets in 2025
Figure 27. United States VS China: PSMA-labeled Imaging Ligands Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: PSMA-labeled Imaging Ligands Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: PSMA-labeled Imaging Ligands Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share 2025
Figure 31. China Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share 2025
Figure 32. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share 2025
Figure 33. World PSMA-labeled Imaging Ligands Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World PSMA-labeled Imaging Ligands Production Value Market Share by Type in 2025
Figure 35. Gallium-68?Ga-68?
Figure 36. Fluorine-18?F-18?
Figure 37. World PSMA-labeled Imaging Ligands Production Market Share by Type (2021-2032)
Figure 38. World PSMA-labeled Imaging Ligands Production Value Market Share by Type (2021-2032)
Figure 39. World PSMA-labeled Imaging Ligands Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World PSMA-labeled Imaging Ligands Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Figure 41. World PSMA-labeled Imaging Ligands Production Value Market Share by Dosage in 2025
Figure 42. Ready-to-use Drug
Figure 43. Kit-based Radiolabeling
Figure 44. World PSMA-labeled Imaging Ligands Production Market Share by Dosage (2021-2032)
Figure 45. World PSMA-labeled Imaging Ligands Production Value Market Share by Dosage (2021-2032)
Figure 46. World PSMA-labeled Imaging Ligands Average Price by Dosage (2021-2032) & (US$/Unit)
Figure 47. World PSMA-labeled Imaging Ligands Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World PSMA-labeled Imaging Ligands Production Value Market Share by Application in 2025
Figure 49. Initial Staging
Figure 50. Biochemical Recurrence
Figure 51. Theranostics Selection
Figure 52. Others
Figure 53. World PSMA-labeled Imaging Ligands Production Market Share by Application (2021-2032)
Figure 54. World PSMA-labeled Imaging Ligands Production Value Market Share by Application (2021-2032)
Figure 55. World PSMA-labeled Imaging Ligands Average Price by Application (2021-2032) & (US$/Unit)
Figure 56. PSMA-labeled Imaging Ligands Industry Chain
Figure 57. PSMA-labeled Imaging Ligands Procurement Model
Figure 58. PSMA-labeled Imaging Ligands Sales Model
Figure 59. PSMA-labeled Imaging Ligands Sales Channels, Direct Sales, and Distribution
Figure 60. Methodology
Figure 61. Research Process and Data Source
Figure 1. PSMA-labeled Imaging Ligands Picture
Figure 2. World PSMA-labeled Imaging Ligands Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World PSMA-labeled Imaging Ligands Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 5. World PSMA-labeled Imaging Ligands Average Price (2021-2032) & (US$/Unit)
Figure 6. World PSMA-labeled Imaging Ligands Production Value Market Share by Region (2021-2032)
Figure 7. World PSMA-labeled Imaging Ligands Production Market Share by Region (2021-2032)
Figure 8. North America PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 9. Europe PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 10. China PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 11. Japan PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 12. India PSMA-labeled Imaging Ligands Production (2021-2032) & (Units)
Figure 13. PSMA-labeled Imaging Ligands Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 16. World PSMA-labeled Imaging Ligands Consumption Market Share by Region (2021-2032)
Figure 17. United States PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 18. China PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 19. Europe PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 20. Japan PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 21. South Korea PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 22. ASEAN PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 23. India PSMA-labeled Imaging Ligands Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of PSMA-labeled Imaging Ligands by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for PSMA-labeled Imaging Ligands Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for PSMA-labeled Imaging Ligands Markets in 2025
Figure 27. United States VS China: PSMA-labeled Imaging Ligands Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: PSMA-labeled Imaging Ligands Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: PSMA-labeled Imaging Ligands Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share 2025
Figure 31. China Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share 2025
Figure 32. Rest of World Based Manufacturers PSMA-labeled Imaging Ligands Production Market Share 2025
Figure 33. World PSMA-labeled Imaging Ligands Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World PSMA-labeled Imaging Ligands Production Value Market Share by Type in 2025
Figure 35. Gallium-68?Ga-68?
Figure 36. Fluorine-18?F-18?
Figure 37. World PSMA-labeled Imaging Ligands Production Market Share by Type (2021-2032)
Figure 38. World PSMA-labeled Imaging Ligands Production Value Market Share by Type (2021-2032)
Figure 39. World PSMA-labeled Imaging Ligands Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World PSMA-labeled Imaging Ligands Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Figure 41. World PSMA-labeled Imaging Ligands Production Value Market Share by Dosage in 2025
Figure 42. Ready-to-use Drug
Figure 43. Kit-based Radiolabeling
Figure 44. World PSMA-labeled Imaging Ligands Production Market Share by Dosage (2021-2032)
Figure 45. World PSMA-labeled Imaging Ligands Production Value Market Share by Dosage (2021-2032)
Figure 46. World PSMA-labeled Imaging Ligands Average Price by Dosage (2021-2032) & (US$/Unit)
Figure 47. World PSMA-labeled Imaging Ligands Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World PSMA-labeled Imaging Ligands Production Value Market Share by Application in 2025
Figure 49. Initial Staging
Figure 50. Biochemical Recurrence
Figure 51. Theranostics Selection
Figure 52. Others
Figure 53. World PSMA-labeled Imaging Ligands Production Market Share by Application (2021-2032)
Figure 54. World PSMA-labeled Imaging Ligands Production Value Market Share by Application (2021-2032)
Figure 55. World PSMA-labeled Imaging Ligands Average Price by Application (2021-2032) & (US$/Unit)
Figure 56. PSMA-labeled Imaging Ligands Industry Chain
Figure 57. PSMA-labeled Imaging Ligands Procurement Model
Figure 58. PSMA-labeled Imaging Ligands Sales Model
Figure 59. PSMA-labeled Imaging Ligands Sales Channels, Direct Sales, and Distribution
Figure 60. Methodology
Figure 61. Research Process and Data Source
